fbpx

A new culprit in diabetic retinopathy

Researchers at Johns Hopkins University have discovered that the protein ANGPTL4 (Angiopoietin-like 4) contributes to the proliferation of leaky blood vessels in the eye in patients with diabetic retinopathy, leading to a loss of vision and eventually permanent blindness.

Recently developed drugs for treating diabetic retinopathy that target the protein VEGF delay the progress of the disease but do not halt it completely, and the drugs are ineffective for some patients.

Laboratory tests showed that when both ANGPTL4 and VEGF were blocked the growth of blood vessels was drastically reduced, indicating that new treatments that target both proteins would be more effective than drugs targeting VEGF alone.

Further studies are being done to see if ANGPTL4 plays a role in other eye diseases, such as AMD.

Further information: http://www.hopkinsmedicine.org/news/media/releases/study_suggests_new_way_of_preventing_diabetes_associated_blindness

Spring allergens linked to dry eye

Researchers at the University of Miami have, for the first time, found a link between airborne allergens and dry eye.

After looking at the records of 3.4 million visits to Veterans Affairs eye clinics between 2006 and 2011, the researchers compared the 607,000 visits for dry eye and the allergy index over time and found that incidences of dry eye followed seasonal patterns.

The researchers observed a spike in dry eye cases each spring. April, the peak of the allergy season, had the highest rate of dry eye cases of any month. A smaller spike occurred in winter, while summer had the lowest incidence of dry eye cases.

Sufferers of springtime dry eye may benefit from taking steps to minimize exposure to airborne allergens, such as wearing goggles when working outdoors and installing air filters in their homes, in addition to dry eye treatments.

Further information: http://www.medicalnewstoday.com/releases/293005.php

Garneau College Launches New Acuvue Contact Lens Space

The new contact lens clinical and dispensing training space opened this past May 14 in the presence of all the partners involved in this major project.

Open to the public, Lunetterie Garneau treats some 1,000 clients per year who reside on the outskirts of Quebec City. Lunetterie Garneau’s growing clientele come to the clinic for its distinctive services, reasonable prices, and wide selection of products, while the optical science students who train there benefit from invaluable, practical experience.

Before this dedicated space opened, the contact lens area wasn’t very functional. It took the determination of optical science teacher Karine Lacourse, the project co-manager, and the commitment of Garneau College and its partners to turn this dream into a reality. ”Many students have told us how much more professional they feel in this new setting.  The space is very well equipped and laid out now, making it much easier for us teachers to share our passion for contact lenses. The space was designed to work as a classroom and a clinic, and has been completely renovated and revamped. It’s now fully functional and modern thanks to cutting edge new equipment,” said Lacourse.

The new space was christened Acuvue, a trademark of Johnson & Johnson, after its main donor. CooperVision, AXIS Medical Group, and Blanchard Contact Lenses were also instrumental in supporting this very important training ground for optical students.

 

California relists BpA as hazardous, optical industry responds

California has relisted Bisphenol A (BpA), a chemical important to the optical industry as a starting material for the production of polycarbonate lenses, on the list of hazardous substances known to cause cancer or birth defects and regulated under Proposition 65, the Safe Drinking Water and Toxic Enforcement Act.

Products sold in California with levels of hazardous substances greater than the legal limit must come with clear warning labels or face stiff penalties.

The Vision Council, a body that represents manufacturers and suppliers of the optical industry, is reviewing the new ruling to determine if California is providing a “safe harbour” level for BpA. When BpA was previously listed under Prop 65 the safe harbour was above the levels of BpA encountered by consumers in optical products. Products with levels of hazardous substances below the safe harbour are not required to issue warning labels.

Further Information: http://www.thevisioncouncil.org/blog/bpa-added-california-proposition-65-list

Jerry Warner Appointed as CooperVision President, North America

CooperVision Inc. named Jerry Warner as President, North America, responsible for determining the strategic direction of North America, the company’s largest region, driving sustainable business growth and deeper customer relationships in the United States and Canada. The company confirmed to VuePoint that Tom Konstantas, General Manager, Cooper Vision Canada reports to Mr. Warner in his new position.

Mr. Warner joined CooperVision in 2012, and most recently held the position of Senior Vice President of Global Marketing.  Prior to joining CooperVision, he spent 17 years with Bausch & Lomb in various marketing positions in the contact lens and lens care areas with both global and North American responsibilities. Earlier in his career, Mr. Warner served in a variety of sales, marketing and trade marketing roles with Bristol Myers Squibb at the territory and sales management levels.

“Jerry has extensive vision care experience, having spent the past two decades working hand-in-hand with eye care practitioners, retailers, researchers, educators, field sales teams and others in global and regional roles,” said Dennis Murphy, Executive Vice President of Global Sales and Marketing at CooperVision.

“CooperVision has always enjoyed a mutually beneficial relationship with prescribing practitioners, and I look forward to extending and deepening that bond as we grow together.” said Mr, Warner.

Mr. Warner earned an MBA from the Simon School, University of Rochester, and holds a bachelor’s degree in business administration from Villanova University. His primary office will be in Fairport, N.Y.

Featured Posts

Managing anxious children optometry pre-testing

Pivot to Patience: Managing the Emotionally Elevated Child in Pre-Testing

Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.

Learn More
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Read more
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read more
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read more
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read more
Managing anxious children optometry pre-testing

Pivot to Patience: Managing the Emotionally Elevated Child in Pre-Testing

Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.

Learn More
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Read More
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read More
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read More
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read More
Managing anxious children optometry pre-testing

Pivot to Patience: Managing the Emotionally Elevated Child in Pre-Testing

Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.

Learn More
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Read more
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read more
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read more
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read more
Managing anxious children optometry pre-testing

Pivot to Patience: Managing the Emotionally Elevated Child in Pre-Testing

Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.

Learn More
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Read more
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read more
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read more
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read more